Bret Kinsella and Joseph Benson
To leverage the science of momentum and apply it to art of brand management.
Abstract
Purpose
To leverage the science of momentum and apply it to art of brand management.
Design/methodology/approach
Researches the brand literature. Revisits our understanding of Newtonian physics. Studies the history of brands that have experienced the power of momentum. Shares early drafts with fellow brand strategist for feedback and guidance.
Findings
Discovers that the resonance of momentum is real and memorable experience for the authors and for their readers. The authors had underestimated the number of brands that could leverage the concept of momentum to better manage and grow their brands.
Research limitations/implications
The authors believe it would be of value for the brand managers of those brands that are experiencing momentum to analyze the specific activities that are driving their brands.
Practical implications
It is the authors’ hope that brand managers will have a new lens through which to select, engage and measure brand‐building activities.
Originality/value
The authors do not believe that this information is new. They do believe that they have placed it in a context that promotes understanding and action.
Details
Keywords
This paper seeks to investigate the fast‐growing problem of counterfeit prescription drugs and the steps being taken by both the private and public sectors to counteract it.
Abstract
Purpose
This paper seeks to investigate the fast‐growing problem of counterfeit prescription drugs and the steps being taken by both the private and public sectors to counteract it.
Design/methodology/approach
The author documents both the size and scope of the counterfeit pharmaceutical problem in the USA. The paper also looks at the steps being taken by pharmaceutical manufacturers and wholesalers, as well as legal efforts being undertaken by federal and state governments, to counteract the growing concerns over fake medicines being introduced into the pharmaceutical supply chain.
Findings
The paper builds the business case for radio frequency identification (RFID) technology to be employed to track pharmaceuticals in the supply chain and counter the growing threat of counterfeit drugs.
Research limitations/implications
The principal limitation of this research is that it is being conducted on both a rapidly evolving problem (counterfeit pharmaceuticals) and the use of a rapidly developing technology (RFID) to counteract it. Thus, in time, the parameters of both the counterfeit drug problem and the technological solutions to it may shift dramatically.
Practical implications
The paper demonstrates that RFID provides the only effective method of providing “track and trace” electronic pedigrees for prescription drugs.
Originality/value
The paper is a valuable overview of the problems associated with the vulnerability of the pharmaceutical supply chain in the USA and the potential cost‐effective, life‐saving use of RFID to better secure prescription drugs, both in transit and in inventory.
Details
Keywords
Launched in 2014, Amazon's Echo and Echo Dot smart speakers led the category's rapid adoption by households and enabled the penetration of artificial intelligence (AI) voice…
Abstract
Launched in 2014, Amazon's Echo and Echo Dot smart speakers led the category's rapid adoption by households and enabled the penetration of artificial intelligence (AI) voice assistants into the everyday lives of millions of people. By 2019, Alexa the virtual brains behind Amazon's smart speakers was able to play music, create reminders, get weather reports, control lights and other home appliances, shop, and do much more in response to voice commands. Amazon had developed significant new capabilities for Alexa, developed an entire ecosysgtem around it, expanded Alexa's user base to more than 100 million users, and made significant progress in monetizing its digital voice assistant. However, Alexa's progress also created new challenges for Amazon, its Alexa-enabled customers, and society at large. Amazon needed to identify and address these challenges in order to encourage continued consumer acceptance and preclude detrimental government or regulatory action.
Details

Keywords
The purpose of this paper is to provide an overview of rural older veterans in the US and discuss how the US Department of Veterans Affairs (VA) is increasing access to health…
Abstract
Purpose
The purpose of this paper is to provide an overview of rural older veterans in the US and discuss how the US Department of Veterans Affairs (VA) is increasing access to health care for older veterans in rural areas.
Design/methodology/approach
This is a descriptive paper summarizing population and program data about rural veterans.
Findings
VA provides a variety of health care services and benefits for older veterans to support health, independence, and quality of life. With the creation of the Veterans Health Administration Office of Rural Health (ORH) in 2006, the needs of rural veterans, who are on average older than urban veterans, are receiving greater attention and support. ORH and VA have implemented several programs to specifically improve access to health care for rural veterans and to improve quality of care for older veterans in rural areas.
Originality/value
This paper is one of the first to describe how VA is addressing the health care needs of older, rural veterans.